CN112135602A

CN112135602A - Deodorants and deactivators

Info

Publication number: CN112135602A
Application number: CN201980035382.2A
Authority: CN
Inventors: 间中勇太; 山田俊一; 森下薰; 胜山雅子; 落合正敏; 瓦谷明宏; 桑原裕香理; 石川贵大
Original assignee: Takasago International Corp; Shiseido Co Ltd
Current assignee: Takasago International Corp; Shiseido Co Ltd
Priority date: 2018-05-25
Filing date: 2019-05-24
Publication date: 2020-12-25
Anticipated expiration: 2039-05-24
Also published as: WO2019225754A1; JP2024020230A; TW202002938A; CN112135602B; JPWO2019225754A1

Abstract

The present invention provides an odor preventive agent and a passivating agent, which contain at least one component selected from the group consisting of: spearmint oil; mixed lavender oil; peppermint oil; l-citronellal; linalool; dihydromyrcenol; cis-3-hexenol; ligustral; benzyl acetate; rosemary oil; cis-3-hexenyl acetate; lavender oil; (R) -3, 7-dimethyl-6-octenenitrile(ii) a (1R,6S) -2,2, 6-trimethyl-cyclohexanecarboxylic acid ethyl ester; eucalyptus oil;γ-undecalactones; rose oil; (R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol; (-) -isopulegol and the like.

Description

Deodorants and deactivators

RELATED APPLICATIONS

The invention is based on the japanese patent application: the priority claim of application No. 2018-100598 (application on 5/25/2018), the entire description of which is incorporated by reference and described in the present specification.

Technical Field

The present disclosure relates to an deodorant agent that eliminates or alleviates unpleasant feelings caused by body odor. The present disclosure relates to a deactivator for inactivating the physiological/psychogenic active (off-normal) action of secretory components derived from the human body.

Background

The odor derived from an odor component emitted from the skin of a human body is often an unpleasant odor, and is generally called "body odor". For example, "old people smell (aged smell)" which is a body smell peculiar to middle-aged and elderly people is known (for example, see patent document 1). In order to eliminate unpleasant feeling due to old people odor, a component having an excellent masking effect on old people odor and/or a component having an excellent blending effect on old people odor is blended in the fragrance composition for suppressing old people odor described in patent document 1.

In addition, sulfur compounds are generally considered to be unpleasant odor components. Patent document 2 discloses an odor inhibitor of a polysulfide compound selected from butyl 2-methylbutyrate,αAt least one of terpinene, dipentene, cis-4-heptenal, 1, 4-cineole, trimethylhexanal and (+) -limonene oxide as an active ingredient.

Documents of the prior art

Patent document

Patent document 1: japanese patent laid-open publication No. 11-286428;

patent document 2: WO2016/204212A 1.

Disclosure of Invention

Problems to be solved by the invention

The inventors noted that: a peculiar smell is present around a person who is in a state of stress (stress state) in which the heart rate is increased by mental stress. Therefore, the present inventors have found, when studying the cause of the odor: the odor is body odor caused by substances secreted/released by a person in a state of stress or mental stress (hereinafter, referred to as "stress odor" or "stress odor" in the present disclosure).

The nervous odor is a sulfurous odor, which is unpleasant for many people. In recent years, attention to body odor has been increasing, and there is expected to be an increasing demand for an odor preventive agent that can eliminate or alleviate unpleasant feelings caused by intense odor.

The odor inhibitor described in patent document 2 only mentions malodors originating from other than human bodies, such as drain outlets and kitchen waste, and no discussion is made about malodors emitted from human bodies, and it is not clear whether the odor inhibitor described in patent document 2 can inhibit stress odor.

The inventor considers that: at least one of a physiologically active action and a psychoactive action exists in a component secreted and released from a person in a state of stress or psychogenic stress (for example, a substance causing stress and odor). Therefore, there is an increasing demand for a deactivator which inactivates physiologically and/or psychologically active actions due to components secreted from a person in a state of stress and/or psychogenic stress (hereinafter, referred to as "stress odor components").

Means for solving the problems

According to a1 st aspect of the present disclosure, there is provided an tension odor preventive agent comprising at least one component selected from the group consisting of:<1>spearmint oil;<2>lavandin oil (lavandin oil);<3>peppermint oil;<4>l-citronellal;<5>linalool;<6>dihydromyrcenol (dihydromyrcenol);<7>cis-3-hexenol;<8>ligustral;<9>benzyl acetate;<10>rosemary oil;<11>cis-3-hexenyl acetate;<12>lavender oil (lavender oil);<13>(R) -3, 7-dimethyl-6-octenenitrile;<14>(1R,6S) -2,2, 6-trimethyl-cyclohexanecarboxylic acid ethyl ester;<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol;<19>(-) -isopulegol;<20>2- (tert-butyl) cyclohexyl acetate;<21> β-damascone;<22>hexyl acetate;<23>l-cis-rose oxide;<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol;<26>cedar oil;<27>geranium oil;<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene;<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal;<33>2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone;<34>terpineol; and combinations thereof.

According to a 2 nd aspect of the present disclosure, there is provided a passivating agent comprising at least one component selected from the group consisting of:<1>spearmint oil;<2>mixed lavender oil;<3>peppermint oil;<4>l-citronellal;<5>linalool;<6>dihydromyrcenol;<7>cis-3-hexenol;<8>ligustral;<9>benzyl acetate;<10>rosemary oil;<11>cis-3-hexenyl acetate;<12>lavender oil;<13>(R) -3, 7-dimethyl-6-octenenitrile;<14>(1R,6S) -2,2, 6-trimethyl-cyclohexanecarboxylic acid ethyl ester;<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol;<19>(-) -isopulegol;<20>2- (tert-butyl) cyclohexyl acetate;<21> β-damascone;<22>hexyl acetate;<23>l-cis-rose oxide;<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol;<26>cedar oil;<27>geranium oil;<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene;<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal;<33>2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone;<34>terpineol; and combinations thereof. The passivator passivates the psychogenic and/or psychogenic activity of the secretory component.

Effects of the invention

According to the deodorant agent of the present disclosure, unpleasant feeling due to tension odor can be eliminated or reduced.

The deactivant according to the present disclosure may inactivate or inhibit the psychologically or physiologically active effects of the stress odour component.

Drawings

FIG. 1 is a graph showing the results in example 5.

Detailed Description

Preferred embodiments from the above viewpoints are described below.

According to a preferred aspect of the above aspect 1, the tension odor preventive agent contains at least one of the components <1> to <34> and combinations thereof as a masking agent against tension odor.

According to a preferred embodiment of the above aspect 1, the tension odor preventive agent contains at least one of the components <1> to <22> and combinations thereof as a blending agent against tension odor.

According to a preferred embodiment of the above aspect 1, the tension odor preventive agent contains at least one of the components <1> to <22> and combinations thereof as a masking agent/harmonizing agent for tension odor.

According to a preferred embodiment of the above aspect 1, the stress odor is an odor emitted from the body due to stress and/or psychological stress.

According to a preferred embodiment of the above aspect 1, the substance causing stress and odor contains at least one of allyl mercaptan and dimethyl trisulfide.

According to a preferred embodiment of the above aspect 1, the causative agent further contains at least one of dimethyl disulfide and methyl propyl trisulfide.

According to a preferred mode of the above viewpoint 1, the causative agent further comprises 1-octen-3-one.

According to a preferred embodiment of the above aspect 2, the secretory component is a component that is secreted by the body due to stress and/or mental stress.

In a preferred embodiment according to the above aspect 2, the secretory component includes at least one of allyl thiol and dimethyl trisulfide.

According to a preferred embodiment of the above aspect 2, the secretory component further contains at least one of dimethyl disulfide and methylpropyl trisulfide.

According to a preferred embodiment of the above aspect 2, the secretory component further comprises 1-octen-3-one.

An odor inhibitor according to embodiment 1 of the present disclosure will be described.

The deodorant of the present disclosure is a deodorant that can be suitably applied to body odor (tension odor) emitted when a person is in a state of tension and/or mental stress. The term "odor-prevention" as used in the present disclosure means a sensory effect, and causes an odor to be prevented from being perceived or alleviated (hereinafter, referred to as "malodor"). The deodorizing action of the deodorant of the present disclosure may be considered to be a masking action (masking effect) and a harmonizing action (harmonizing effect). In the present disclosure, masking means that a good fragrance (aroma ) rather than malodor is opposed to malodor, while malodor is relatively prevented (elimination or alleviation of malodor). In addition, in the present disclosure, harmonization means mixing a fragrance harmonized with malodor to harmonize the malodor as a whole (for example, converting malodor into fragrance/aroma), thereby preventing malodor (eliminating or moderating malodor).

The deodorant of the present disclosure contains at least one of the following listed ingredients as the 1 st deodorant ingredient:

<1>spearmint oil;<2>lavandin oil (lavandin oil);<3>peppermint oil (peppermint oil);<4>l-citronellal;<5>linalool;<6>dihydromyrcenol (2, 6-dimethyl-7-octen-2-ol);<7>cis-3-hexenol;<8>ligustral (dimethyl-3-cyclohexene-1-carbaldehyde);<9>benzyl acetate;<10>rosemary oil (rosemary oil);<11>cis-3-hexenyl acetate;<12>lavender oil;<13>(R) -3, 7-dimethyl-6-octenenitrile (as a commercially available product, for example, LEVOCITRILE (registered trademark: high sand spices industries));<14>(1R,6S) -ethyl 2,2, 6-trimethyl-cyclohexanecarboxylate (as a commercially available product, e.g., THESARON (registered trademark: high sand perfumery industries));<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol (as a commercially available product, e.g., HINNOL (registered trademark: high-sand perfumery industries));<19>(-) -isopulegol (as a commercial product, for example, COOLACT (registered trademark: high-sand perfumery Co., Ltd.) P);<20>2- (tert-butyl) cyclohexyl acetate (as commercially available product, for example, VERDOX (International Flavors)&Fragrans (iff) corporation));<21> β-damascone (1- (2-butenoyl) -2,6, 6-trimethyl-1, 3-cyclohexadiene);<22>hexyl acetate;<23>l-cis-rose oxide ((2S,4R) -tetrahydro-4-methyl-2- (2-methyl-1-propenyl) -2H-pyran);<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol (as a commercial product, for example, DIHYDRO citrus elol (high sand perfumery industries));<26>cedar oil;<27>geranium oil；<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene (as a commercial product, for example, ORBITONE (registered trademark: high sand perfumery industries));<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal (as a commercial product, e.g., BIOMUGUET (registered trademark: Gaosha flavor industries));<33>2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone (as a commercial product, for example, RINGONOL (registered trademark: high-sand perfumery industries, Ltd.) 50);<34>terpineol;<35>lyme oil;<36>orange peel oil;<37>lemon oil;<38>isoeugenol;<39>phenylacetaldehyde;<40> α-hexyl cinnamic aldehyde;<41>cyclamen aldehyde (3- (4-isopropylphenyl) isobutyraldehyde);<42>1- (5, 5-dimethyl-1-cyclohexen-1-yl) -4-penten-1-one (commercially available, for example, DYNASCONE (registered trademark: Firmenich Co.)));<43>3- (4-methoxyphenyl) -2-methylpropionaldehyde (commercially available, for example, CANTHOXAL (IFF corporation));<44>1,1,2,3, 3-pentamethyl-6, 7-dihydroindan-4 (5H) -one (commercially available, e.g., CASHMERAN (IFF corporation));<45>trans-β-damascone;<46>trans-α-damascone;<47>hexyl salicylate;<48>isocyclocitral (2,4, 6-trimethyl-3-cyclohexene-1-carbaldehyde);<49> α-amyl cinnamic aldehyde;<50>2-nonanoic acid methyl ester;<51>methyl anthranilate;<52>linalyl acetate;<53>octanal;<54>decanal;<55>dodecanal;<56>salicylic acid cis-3-hexen-1-yl ester;<57>allyl amyl glycolate;<58>methyl (Z) -3-hexenyl carbonate;<59>5-methyl-3-heptanone oxime (as a commercially available product, for example, STEMONE (registered trademark: Givaudan Co.));<60>2-tricyclo [5.2.1.02, 6]]Ethyl decan-2-ylcarboxylate (as a commercially available product, e.g., FRUITATE (registered trademark: Kao corporation));<61>allyl caproate;<62>allyl cyclohexanepropanoate;<63>anethole;<64>thymol;<65>cis-jasmone;<66>2' -naphthaleneacetone;<67>4-methoxytoluene;<68>p-anisaldehyde;<69> β-ionone;<70>coumarin;<71>methyl cinnamate;<72>maltol;<73>ethyl maltol;<74>isobutylquinoline;<75>2-isobutylquinoline; and combinations thereof.

The deodorant of the present disclosure preferably contains at least one selected from the above-mentioned components <1> to <37> and combinations thereof as a masking agent. When the deodorant of the present disclosure is a masking agent, it more preferably contains at least one component selected from the above-mentioned components <1> to <24>, <26>, <27>, <31>, and <35> to <37> and combinations thereof, and still more preferably contains at least one component selected from the above-mentioned components <1> to <6> and <35> and combinations thereof, from the viewpoint of masking effect.

The deodorant of the present disclosure preferably contains at least one selected from the above-mentioned components <1> to <22> and <35> to <37> and combinations thereof as a blending agent. When the deodorant of the present disclosure is a blending agent, from the viewpoint of a blending effect, it is more preferable to contain at least one component selected from the above-mentioned components <1> to <19> and <35> to <37> and a combination thereof, and it is further preferable to contain at least one component selected from the above-mentioned components <1> to <18> and a combination thereof.

The deodorant of the present disclosure can have both masking effect and harmonizing effect. That is, the deodorant of the present disclosure may include a masking agent and a blending agent. In particular, the components <1> to <22> and <35> to <37> and the combination thereof have both a masking effect and a harmonizing effect, and therefore, stress odor can be effectively prevented.

A method of using the deodorant of the present disclosure and a method of deodorizing a strong odor will be described.

The deodorant of the present disclosure can be dispersed in the air in a place where stress odor is generated and/or a place where stress odor is likely to be generated, in advance of and/or after the occurrence of stress odor. The deodorant may be attached to or spread on clothing, curtains, carpets, etc., before and/or after the event. The deodorant can be applied to the skin before and/or after the skin is cleaned without adversely affecting the skin. For example, the deodorant can be applied to a part which is thought to secrete a tense odor component, such as the palm, the underarm, the foot, the back, the head, the face, the oral cavity, and the like.

The deodorant of the present disclosure may be used in combination with other deodorants, substances that remove or alleviate malodor by chemical/biological/physical action, or the like. For example, the deodorant of the present disclosure may further contain a deodorizing component, another deodorizing component, and the like, in a range that does not impair the effects of the deodorant of the present disclosure.

According to the deodorant of the present disclosure, unpleasant sensations produced when a person smells a tense odor can be eliminated or alleviated. In addition, by using the deodorant of the present disclosure, a person who is in a state of tension or psychological stress, a person who has been in a state of tension or psychological stress, or a person who is likely to be in a state of tension or psychological stress in the future, it is possible to eliminate or reduce a sense of uneasiness which is likely to generate a state of tension or a state of psychological stress in advance and/or afterward.

An odor inhibitor according to embodiment 2 of the present disclosure will be described.

The deodorant according to embodiment 2 may further contain a 2 nd deodorizing component for physically and chemically preventing tension odor (deodorization) in addition to the deodorant according to embodiment 1. The No. 2 deodorizing component is a substance that removes or alleviates (deodorizes) malodor by chemical and/or physical action on substances that cause malodor. It should be noted that even if the components listed in the present disclosure remove or mitigate malodors by means other than chemical and/or physical action, the range of the deodorant of the present disclosure is not exceeded.

The 2 nd deodorizing component comprises at least one of the 1 st deodorizing component and the 2 nd deodorizing component.

The 1 st deodorizing component may comprise at least one selected from the group 1 consisting of silver-loaded zeolite, tocopherol, zinc oxide, ginger cassummunar (Zingiber cassumunar) extract, ginger zerumbet (Zingiber zerumbet) extract, and combinations thereof. The 1 st deodorizing component is considered to be useful for deodorizing substances causing stress odor, particularly malodors caused by allyl mercaptan.

In the present disclosure, the silver-loaded zeolite includes, for example, a zeolite in which at least a part of ion-exchangeable ions in the zeolite is substituted with silver ions. The silver ion content in the silver-loaded zeolite can be set to, for example, 0.1 to 15 mass%.

The deodorizing component 2 may comprise a compound selected from the group consisting of Laponite (Laponite), silver-loaded zeolite, zinc oxide, Neem leaf (Neem leaf) extract, Iris root (Iris root) extract, perilla leaf extract, hydroxypropyl-β-at least one of group 2 of cyclodextrin, a herbal extract (Hedychium spicatum), tocopherol, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, green tea extract, and combinations thereof. The 2 nd deodorizing component is considered to be useful for deodorizing substances causing stress odor, particularly malodors caused by dimethyl trisulfide.

The 2 nd deodorizing component preferably comprises (a) zinc oxide; and (B) is selected from laponite, silver-carrying zeolite, dibutylhydroxytoluene, sugar cane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-at least one of group 3 of cyclodextrins, tsaoko extracts, green tea extracts, and combinations thereof. When this combination is used, the deodorizing effect of stress odor can be further improved.

Fine powders of zinc oxide can be used. The average particle diameter of zinc oxide can be set to 5, for exampleμm is less than 3μm is less than or equal to 2μm is less than 1μm is less than or equal to 0.5μm is less than or equal to m.

As described later, the main components of the substances responsible for stress and odor are allyl mercaptan and dimethyl trisulfide. These two substances have particularly great influence on the sense of smell. Therefore, if the odor of allyl mercaptan and dimethyl trisulfide is deodorized, the odor of stress can be effectively deodorized.

The No. 2 deodorizing component has deodorizing effect on nervous odor. Thus, according to the deodorant according to embodiment 2, the combination of the 1 st deodorant component and the 2 nd deodorant component can further improve the deodorant effect of the offensive odor.

A passivating agent according to embodiment 3 of the present disclosure will be described.

The stress odor component has at least one of psychologically active action and physiologically active action on human. For example, in the case where a person feels stress odor, in the case where an olfactory receptor responds to a stress odor component, or the like, the person becomes fatigued, disorganized, and wakened more and more noticeably in mind. The tension odour component may also have psychoactive and/or psychoactive effects other than these. The passivator of the present disclosure has the effect of inactivating psychoactive and/or psychoactive effects such as stress odor components. That is, a person may eliminate or inhibit the psychogenic and/or psychological biases as described above in the case that the person perceives the scent of a deactivant of the present disclosure, in the case that the scent and the nervousness of the deactivant mix and are smelled, in the case that olfactory receptors respond to the deactivant, and so on.

In particular, it has been clarified that: if a person perceives tension and smelling, the negative mood will increase. In addition, it is clear that there is a tendency that the positive mood is reduced. As negative emotions, for example, there can be cited: "anger/hostility", "confusion/confusion", "depression/sinking", "fatigue/lassitude" and "tension/unease" examined in accordance with POMS (registered trademark) (Mood state scale, Profile of Mood States). It is known that the tension and odor can particularly improve the "disorder/confusion", "fatigue/lassitude" and "tension/unease" therein. In addition, as positive emotions, for example, "active/active" and "friendly" can be cited.

The passivation agent of the present disclosure includes at least one of the following listed ingredients as the 1 st passivation ingredient:

<1>spearmint oil;<2>lavandin oil (Lavandin oil);<3>peppermint oil;<4>l-citronellal;<5>linalool;<6>dihydromyrcenol (2, 6-dimethyl-7-octen-2-ol);<7>cis-3-hexenol;<8>ligustral (dimethyl-3-cyclohexene-1-carbaldehyde);<9>benzyl acetate;<10>rosemary oil (rosemary oil);<11>cis-3-hexenyl acetate;<12>lavender oil;<13>(R) -3, 7-dimethyl-6-octenenitrile (as commercially available)Products such as LEVOCITRILE (registered trademark: high sand spices industries));<14>(1R,6S) -ethyl 2,2, 6-trimethyl-cyclohexanecarboxylate (as a commercially available product, e.g., THESARON (registered trademark: high sand perfumery industries));<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol (as a commercially available product, e.g., HINNOL (registered trademark: high-sand perfumery industries));<19>(-) -isopulegol (as a commercial product, for example, COOLACT (registered trademark: high-sand perfumery Co., Ltd.) P);<20>2- (tert-butyl) cyclohexyl acetate (as commercially available product, for example, VERDOX (International Flavors)&Fragrans (iff) corporation));<21> β-damascone (1- (2-butenoyl) -2,6, 6-trimethyl-1, 3-cyclohexadiene);<22>hexyl acetate;<23>l-cis-rose oxide ((2S,4R) -tetrahydro-4-methyl-2- (2-methyl-1-propenyl) -2H-pyran);<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol (as a commercial product, for example, DIHYDRO citrus elol (high sand perfumery industries));<26>cedar oil;<27>geranium oil;<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene (as a commercial product, for example, ORBITONE (registered trademark: high sand perfumery industries));<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal (as a commercial product, e.g., BIOMUGUET (registered trademark: Gaosha flavor industries));<33>2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone (as a commercial product, for example, RINGONOL (registered trademark: high-sand perfumery industries, Ltd.) 50);<34>terpineol;<35>lyme oil;<36>orange peel oil;<37>lemon oil;<38>isoeugenol;<39>phenylacetaldehyde;<40> α-hexyl cinnamic aldehyde;<41>cyclamen aldehyde (3- (4-isopropylphenyl) isobutyraldehyde);<42>1- (5, 5-dimethyl-1-cyclohexen-1-yl) -4-penten-1-one (commercially available, for example, DYNASCONE (registered trademark: Firmenich Co.)));<43>3- (4-methoxyphenyl) -2-methylpropionaldehyde (commercially available, for example, CANTHOXAL (IFF corporation));<44>1,1,2,3, 3-pentamethyl-6, 7Dihydroindan-4 (5H) -one (commercially available, e.g. CASHMERAN (IFF corporation));<45>trans-β-damascone;<46>trans-α-damascone;<47>hexyl salicylate;<48>isocyclocitral (2,4, 6-trimethyl-3-cyclohexene-1-carbaldehyde);<49> α-amyl cinnamic aldehyde;<50>2-nonanoic acid methyl ester;<51>methyl anthranilate;<52>linalyl acetate;<53>octanal;<54>decanal;<55>dodecanal;<56>salicylic acid cis-3-hexen-1-yl ester;<57>allyl amyl glycolate;<58>methyl (Z) -3-hexenyl carbonate;<59>5-methyl-3-heptanone oxime (as a commercially available product, for example, STEMONE (registered trademark: Givaudan Co.));<60>2-tricyclo [5.2.1.02, 6]]Ethyl decan-2-ylcarboxylate (as a commercially available product, e.g., FRUITATE (registered trademark: Kao corporation));<61>allyl caproate;<62>allyl cyclohexanepropanoate;<63>anethole;<64>thymol;<65>cis-jasmone;<66>2' -naphthaleneacetone;<67>4-methoxytoluene;<68>p-anisaldehyde;<69> β-ionone;<70>coumarin;<71>methyl cinnamate;<72>maltol;<73>ethyl maltol;<74>isobutylquinoline;<75>2-isobutylquinoline; and combinations thereof.

From the viewpoint of passivation effect, the passivation agent of the present disclosure preferably contains at least one selected from the above-described components <1> to <37> and combinations thereof, more preferably contains at least one selected from the above-described components <1> to <24>, <26>, <27>, <31> and <35> to <37>, and combinations thereof, and still more preferably contains at least one selected from the above-described components <1> to <6> and <35>, and combinations thereof.

The psychological and physiological activities of the tonic and odorous components and the inactivation of the tonic and odorous components by the deactivators can be investigated, for example, by means of a psychological questionnaire, such as POMS (registered trademark) (Mood state scale, Profile of Mood States), gacl (general Activity check), and the like.

Methods of using the presently disclosed deactivant and methods of deactivating an offensive odor component are described.

The deactivant of the present disclosure may be dispersed in the air at a locus where an intense malodour component is produced and/or at a locus where an intense malodour component is likely to be produced, before and/or after. The deactivant may also be attached to or distributed on clothing, curtains, carpets and the like before and/or after the event. The skin-care product can be applied to the skin before and/or after the application of the skin-care product without the skin-care product being adversely affected by the application of the skin-care product. For example, the deodorant can be applied to a part which is thought to secrete a tense odor component, such as the palm, the underarm, the foot, the back, the head, the face, the oral cavity, and the like.

The deactivant of the present disclosure may be used in combination with other psychologically/physiologically acting deactivants and the like. For example, the passivation agent of the present disclosure may further contain other passivation agents within a range that does not hinder the effect of the passivation agent of the present disclosure. Examples of other passivating agents include: substances (for example, deodorizing components, etc.) that remove or mitigate malodors (for example, nervous malodors) by chemical/biological/physical action, etc.

The deactivant of the present disclosure may inactivate psychoactive and/or psychoactive effects of the tension odour ingredient. Thus, the psychological and physiological disorders caused by stress and odor components can be eliminated or suppressed. By using the deactivator of the present disclosure, it is possible to take measures such as psychological and physiological biases before and/or after a person who is in a state of stress or psychological stress, a person who has been in a state of stress or psychological stress, or a person who is likely to become in a state of stress or psychological stress in the future.

A passivating agent according to embodiment 4 of the present disclosure will be described.

The passivation agent according to embodiment 4 includes at least one of the 2 nd passivation component and the 3 rd passivation component in addition to the passivation agent according to embodiment 3.

The 2 nd inactivating component may comprise at least one selected from the group 1 consisting of silver-loaded zeolite, tocopherol, zinc oxide, zingiber kasamsuna extract, zingiber zerumbet extract, and a combination thereof. The No. 1 deactivating ingredient is believed to be useful in deactivating malodors caused by stress odor, particularly allyl mercaptan.

The 3 rd inactivating component may comprise a material selected from the group consisting of laponite, silver-loaded zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-at least one of group 2 of cyclodextrin, a herbal extract, tocopherol, butylated hydroxytoluene, a sugar cane extract, a loquat leaf extract, a green tea extract, and combinations thereof. It is believed that the 2 nd inactivating component can be used for inactivating the odor caused by the odor causing substances, especially dimethyl trisulfide.

The 3 rd passivation component preferably comprises (a) zinc oxide; and (B) is selected from laponite, silver-carrying zeolite, dibutylhydroxytoluene, sugar cane extract, loquat leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-at least one of group 3 of cyclodextrins, tsaoko extracts, green tea extracts, and combinations thereof. When this combination is used, the stress odor-inactivating effect can be further improved.

As described later, the main components of the substances responsible for stress and odor are allyl mercaptan and dimethyl trisulfide. These two substances have particularly great influence on the sense of smell. Therefore, if the odor of allyl mercaptan and dimethyl trisulfide is deodorized, the psychoactive and/or physiologically active effects due to stress odor can be effectively deactivated.

The deactivator according to embodiment 4 can further inactivate psychoactive action and/or psychoactive action due to an offensive odor component by containing a 2 nd inactivating component and/or a 3 rd inactivating component having an action different from that of the 1 st inactivating component.

The method for producing the deodorant and the deactivators of the present disclosure is not particularly limited. For example, the deodorant and deactivant may be prepared by mixing deodorant ingredients.

The tension odor and tension odor components referred to in this disclosure will be explained.

The nervous odor refers to the odor generated by body when in stress or mental stress. Examples of the tension or mental stress include: stress or stress based on interpersonal relationships, etc. Examples of stress/stress based on the presence of a person are: stress/stress during delivery in the presence of others (particularly in the presence of people), stress/stress during receiving important interviews or stressful interviews, and the like. Such a state of mental stress may for example also be: in the absence of an increase in heart rate due to exercise, the heart rate will be above 20bpm (beats every 1 minute) and preferably above 30bpm for calm periods. The calm state is a state where there is no mental stress, the state is quiet, and the heart rate fluctuation is small, for example, a state where the user is relaxed while sitting for a predetermined time or longer.

Stress odor is considered to be based on components contained in blood. In the present disclosure, "produced (secreted/released) from within the body" means produced (secreted/released) from the skin, mucosa and/or oral cavity. The term "body odor" in this disclosure also includes halitosis.

The stress odor component comprises a compound containing elemental sulfur (sulfur compound). Examples of the sulfur compound include at least one of allyl mercaptan and dimethyl trisulfide. Preferably, the stress odour component comprises both allyl mercaptan and dimethyl trisulfide.

The allyl mercaptan may be 0.1ppb or more, 0.3ppb or more, 0.5ppb or more, 1ppb or more, or 10ppb or more in terms of volume standard. The allyl mercaptan may be 1,000ppm or less, 100ppm or less, 10ppm or less, 1ppm or less, 500ppb or less, 100ppb or less, or 10ppb or less in terms of volume standard.

The dimethyltrisulfide may be 1ppb or more, 2ppb or more, 3ppb or more, 5ppb or more, 10ppb or more, 20ppb or more, 50ppb or more or 100ppb or more in terms of volume standard. The dimethyltrisulfide may be 10,000ppm or less, 1,000ppm or less, 100ppm or less, 10ppm or less, 1ppm or less, 100ppb or less or 10ppb or less in terms of volume standard.

In the tension odor component, the mass ratio of allyl mercaptan to dimethyl trisulfide may be, for example, 2 parts by mass or more, 5 parts by mass or more, 10 parts by mass or more, or 15 parts by mass or more, relative to 1 part by mass of allyl mercaptan. The mass ratio of allyl mercaptan to dimethyl trisulfide may be, for example, 50 parts by mass or less, 40 parts by mass or less, 30 parts by mass or less, or 25 parts by mass or less with respect to 1 part by mass of allyl mercaptan.

The tension odor component sometimes further contains at least one compound selected from the group consisting of hydrogen sulfide, methyl mercaptan, carbon disulfide, dimethyl sulfide, dimethyl disulfide, methyl propyl trisulfide, and combinations thereof as a sulfur compound other than allyl mercaptan and dimethyl trisulfide (hereinafter, referred to as "other sulfur compound"). The total amount of the sulfur compound may be 0.1ppb or more, 1ppb or more, or 10ppb or more in terms of volume standard. The total amount of sulfur compounds may be 10,000ppm or less or 1,000ppm or less on a volume basis.

The stress odor component may contain 1-octen-3-one as a non-sulfur compound in addition to or separately from the sulfur compound. The 1-octen-3-one may be, for example, 0.1ppb or more, 0.5ppb or more, 1ppb or more, 10ppb or more, 100ppb or more or 1ppm or more in terms of volume standard. The 1-octen-3-one may be, for example, 1,000ppm or less, 100ppm or less, 10ppm or less, or 1ppm or less by volume.

Examples

Hereinafter, the deodorant and the deactivator of the present disclosure will be described by way of examples. However, the deodorant and the passivating agent of the present disclosure are not limited to the following examples.

Example 1: masking test and blending test

The tension odor components shown in table 1 were dissolved in medium-chain fatty acids to prepare tension odor medium-chain fatty acid solutions. Secondly, at 100μL of said nervousness medium chain fatty acid solution is admixed with 10μThe deodorant (deactivating agent) shown in table 2 and table 3 of L was used as the 1 st deodorant component (1 st deactivating component) to prepare a test solution of each deodorant. Next, each test solution was allowed to standThe filter papers were soaked in a square of 2cm on a side, respectively. Next, the filter paper was put into a disposable beaker having a capacity of 500mL, and the beaker was sealed with an aluminum foil. After the self-sealing for 30 minutes, a hole having a diameter of about 1cm was formed in the aluminum foil. From smelling the odor, 17 professional panelists (panel) consisting of a perfumer and an evaluator (evaluator) were subjected to sensory evaluation of the masking effect and the harmonizing effect of each deodorant against the intense odor according to the following criteria. The average of the evaluation scores of 17 professional reviewers is shown in tables 2 and 3.

[ Table 1]

[ sensory evaluation of masking Effect ]

And 3, dividing: masking the stress odor very well;

and 2, dividing: well mask tension odor;

1 minute: slightly masking stress odor;

0 minute: it is not possible to mask the nervous odor.

[ sensory evaluation of harmonizing Effect ]

1 minute: blending the tense odor with an odor-resistant agent;

0 minute: it is not accurate to say whether the odor is tense and whether the odor-resistant agent is blended or not blended;

-1 point: the tense odor is not blended with the deodorant.

The deodorant of test examples 1 to 37 had a masking effect score of 1.5 or more, and was found to be effective in alleviating tension odor. In particular, an deodorant having a score of 2 or more, preferably 2.5 or more, has a high masking effect on tension odor.

The odor control agents of test examples 1 to 22 and 35 to 37 had a blending effect score of 0.5 or more, and were found to be effective in reducing unpleasant feelings due to stress and odor. In particular, an deodorant having a score of 0.6 or more, preferably 0.7 or more, has a high effect of harmonizing stress odor.

The deodorant compositions of test examples 1 to 22 and 35 to 37 had both masking effect and blending effect. Therefore, the deodorant compositions of test examples 1 to 22 and 35 to 37 can remarkably reduce unpleasant feeling due to tension odor or can prevent tension odor from being felt by people. In particular, an odor inhibitor having a masking effect score of 2.5 or more and a harmonizing effect score of 0.6 or more can be used for odor control of nervous odor.

[ Table 2]

[ Table 3]

Example 2: deodorization test for dimethyl trisulfide

A deodorant solution of each deodorant was prepared by mixing 0.05 mass% of the deodorant as the 2 nd deodorant component (the 2 nd inactivating component) and 99.95 mass% of dipropylene glycol. 1mL of the deodorant solution and 5X 10 parts by mass of the deodorant per 1 part by mass of the deodorant solution were added^-4The mass part of dimethyl trisulfide was injected into a sample tube having a capacity of 30 mL. The odor in the sample tube was smelled by 3 professional panelists, and the deodorizing effect of each deodorant on dimethyl trisulfide was evaluated according to the following criteria.

[ deodorizing Effect against substances causative of stress odor ]

And 2, dividing: the professional reviewer evaluates that the deodorant has high deodorization effect;

1 minute: the professional reviewer evaluates that the deodorization effect of the deodorant is slightly higher;

0 minute: the professional reviewer evaluates that the deodorant has no deodorizing effect.

The evaluation of the deodorant effect of each deodorant by the deodorant and professional panelists tested is shown in table 4. The evaluations shown in table 4 are the average scores of professional reviewers recorded according to the following criteria. The zinc oxide used in the examples below had an average particle size of about 0.2μm。

A: 2 min;

b: 1.5 minutes or more and less than 2 minutes;

c: 1 minute or more and less than 1.5 minutes;

d: less than 1 minute.

In the deodorants of test examples 51 to 55, the deodorizing effect against dimethyl trisulfide, which is a causative substance of tension odor, was confirmed. Therefore, the deodorants of test examples 51 to 55 are considered to be effective for deodorization against stress odor.

[ Table 4]

Example 3: deodorization test against allyl mercaptan ]

A deodorant solution of each deodorant was prepared by mixing 0.10 mass% of the deodorant as the 2 nd deodorant component (the 2 nd inactivating component) and 99.90 mass% of dipropylene glycol. 1mL of the deodorant solution and 5X 10 parts by mass of the deodorant per 1 part by mass of the deodorant solution were added^-6The allyl mercaptan was injected in parts by mass into a 30 mL-capacity sample tube. The odor in the sample tube was smelled by 3 professional panelists, and the deodorizing effect of each deodorant against allyl mercaptan was evaluated according to the following criteria. The evaluation of the deodorant effect of each deodorant by the deodorant and professional panelists tested is shown in table 5. The evaluation criteria were the same as in example 2.

In the deodorants of test examples 60 to 68, the deodorizing effect against allyl mercaptan, which is a causative substance of stress odor, was confirmed. Therefore, the deodorants of test examples 60 to 68 are considered to be effective for deodorization against stress odor.

[ Table 5]

Example 4: deodorization test against allyl mercaptan ]

A deodorant solution of each deodorant was prepared by mixing 0.10 mass% of the deodorant as the 2 nd deodorant component (the 2 nd inactivating component) and 99.90 mass% of dipropylene glycol. The deodorant contained 50 mass% of zinc oxide as component a and 50 mass% of component B shown in table 3. Dissolving 1mL of deodorant in waterThe sum of the amounts of the liquid and the deodorant was 2.5X 10 parts by mass per 1 part by mass of the deodorant^-6The allyl mercaptan was injected in parts by mass into a 30 mL-capacity sample tube. The odor in the sample tube was smelled by 3 professional panelists, and the deodorizing effect of each deodorant against allyl mercaptan was evaluated according to the following criteria. The evaluation of the deodorant effect of each deodorant by the deodorant and professional panelists tested is shown in table 6. The evaluation criteria were the same as in example 2.

If zinc oxide is mixed with other deodorant, the deodorizing effect can be improved as a whole as compared with the use of the deodorant component alone. For example, when test examples 60, 66, 72, 73 and 75 shown in table 2 and test examples 76, 82, 87, 88 and 90 shown in table 3 were compared, the deodorizing effect was improved as compared with the deodorant alone by adding zinc oxide to the deodorant used in example 2. For example, although laponite, hydroxypropyl-βDextrin, sugar cane extract, loquat leaf extract and green tea extract have low deodorizing effect, but the deodorizing effect can be improved by mixing with zinc oxide. That is, it is considered that these deodorizing components and zinc oxide have a synergistic effect of deodorization. Thus, it is considered that the mixture of plural deodorizing components is more effective for deodorization of stress odor. In particular, a deodorant containing zinc oxide as the 2 nd deodorizing component is considered to be more effective for deodorization against stress odor.

When comparing test example 62 with test example 78, if the amount of zinc oxide is increased relative to the malodor causing substances, the deodorizing effect can be improved. It is thus assumed that: if the amount of the deodorant to be applied is increased relative to the stress odor, the deodorizing effect can be further improved.

[ Table 6]

Example 5: psychogenic/psychogenic action test)

The psychological/psychological changes of the subject due to stress and odor were confirmed by smelling the stress and odor model composition using POMS (registered trademark) and GACL. As a result, it was confirmed that: when the subject smells the nervousness and the smell, the arousal, the fatigue and the confusion can be generated.

Next, if the subject smells the model composition of intense odour and the deodorant of the present disclosure at the same time, no psychological/psychological change as described above was seen in the subject. Thus, it was confirmed that: the deodorant of the present disclosure can inactivate psychogenic/psychogenic effects caused by stress odor (secretory component).

Hereinafter, a test for analyzing changes in mental state using the Profile of the food States Second Edition Short questionnaire for adults using POMS (registered trademark) 2 will be described in detail. In this psychological analysis, from the answers of the questionnaire, psychological states regarding "anger/hostility", "confusion/confusion", "depression/depression", "fatigue/lassitude", and "tension/uneasiness" as indices of negative emotions, and "activity/vitality" and "friendly" as indices of positive emotions can be confirmed. The questionnaire was provided with 5 questions for each index, and each subject was given a score for the emotion mentioned for each question according to the following criteria (the highest score of each index was 20 points).

0 minute: there are no mentioned emotions at all;

1 minute: the emotions mentioned slightly;

and 2, dividing: some of the mentioned emotions;

and 3, dividing: there are quite a few emotions mentioned;

and 4, dividing: there are a very large number of moods mentioned.

First, 8 subjects were allowed to rest for 20 minutes. The subject is then asked to answer the questions of the questionnaire. This examination was regarded as "examination 1".

Next, using the model composition of the lowest concentration recognizable by each subject among the stress odor model compositions shown in table 7, each subject was allowed to smell stress odor continuously for 5 minutes. After that, the subject was asked to answer the same question as examination 1. This examination was referred to as "examination 2".

Next, "examination 3" was performed on a date different from the dates of examination 1 and examination 2. Examination 3 first of all, the subject who performed examination 1 and examination 2 was in a resting state as in examination 1 and reached 20And (3) minutes. Next, compare to 100 used in inspection 2μL catatonic model composition, in an amount of 10μL ratio the sample gas obtained by mixing the deodorant having the composition shown in table 8 was allowed to smell for 5 minutes continuously for each subject. After that, the subject was asked to answer the same question as examination 1.

The average value and standard deviation of the scores for each index in the tests 1 to 3 were calculated. The results are shown in Table 9. The average and standard deviation of the scores for each index are shown in fig. 1.

Comparing the results of inspection 1 and inspection 2 shows that: as shown in fig. 1, negative emotions, particularly stress, confusion and fatigue, are increased by the perception of stress and odor. On the other hand, a tendency to decrease is also confirmed with respect to positive emotions. Thus, it can be seen that: nervous odour has a psychogenic/psychogenic effect that tends to make the mood of the person in an unstable direction.

On the other hand, when comparative examinations 1 to 3 were carried out, it was found that: if the deodorant of the present disclosure is applied to tension odor, the negative mood due to tension odor is not increased. In addition, the positive mood is not lowered. The score of the inspection 3 to which the deodorant of the present disclosure was applied was equal to the score in the quiet state of the inspection 1. Thus, it can be seen that: the deodorants of the present disclosure may inactivate (eliminate, reduce and/or alleviate) the psychogenic/psychogenic effects of stress odor.

When the mixed gas of the tension odor model composition used in examination 3 and the deodorant of the present disclosure was subjected to direct mass analysis, each component of the tension odor model composition was detected. It is thus assumed that: the negative emotion caused by stress odor was not increased in examination 3 because stress odor was not perceived or recognized by the subject by the deodorant of the present disclosure. Thus, it can be seen that: even in the presence of stress odor, if stress odor can be prevented by masking effect and/or harmonizing effect, psychogenic/psychogenic effect caused by stress odor can be inactivated. That is, it is known that the deodorant of the present disclosure can be applied as a deactivator against psychogenic/psychogenic effects caused by stress odor.

[ Table 7]

[ Table 8]

[ Table 9]

Some or all of the above embodiments are described in the following remarks, but are not limited to the following descriptions. The respective remarks may also be combined with the claims presented in the claims.

[ Note 1]

An odor-preventive agent for tension odor, which contains at least one of a1 st deodorizing component and a 2 nd deodorizing component,

the above-mentioned first deodorizing component comprises at least one selected from the group 1 consisting of silver-carrying zeolite, tocopherol, zinc oxide, Kasamsuna ginger extract, Kadsura ginger extract, and a combination thereof,

said deodorizing component 2 comprises a deodorizing component selected from the group consisting of laponite, silver-loaded zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-at least one of group 2 of cyclodextrins, tsaoko extracts, tocopherols, and combinations thereof.

[ Note 2]

the above-mentioned deodorizing component 2 comprises:

zinc oxide; and

selected from the group consisting ofLaponite, silver-carrying zeolite, dibutylhydroxytoluene, sugarcane extract, loquat leaf extract, iris root extract, perilla leaf extract and hydroxypropyl-β-at least one of group 3 of cyclodextrins, tsaoko extracts, green tea extracts, and combinations thereof.

[ Note 3]

A passivating agent comprising at least one of a1 st passivating component and a 2 nd passivating component,

the 1 st inactivating component comprises at least one selected from the group 1 consisting of silver-loaded zeolite, tocopherol, zinc oxide, Zingiber cassumunar extract, Zingiber zerumbet Smith extract, and combinations thereof,

said 2 nd inactivating component comprises a compound selected from the group consisting of laponite, silver-loaded zeolite, zinc oxide, neem leaf extract, iris root extract, perilla leaf extract, hydroxypropyl-β-at least one of group 2 of cyclodextrins, herbal extracts, tocopherols, and combinations thereof,

the passivator can passivate the psychogenic or psychogenic activity of secretory component.

[ Note 4]

the 1 st inactivating component is at least one selected from the 1 st group consisting of silver-carrying zeolite, tocopherol, zinc oxide, Zingiber cassumunar extract, Zingiber zerumbet Smith extract, and combinations thereof,

the passivation component 2 includes:

zinc oxide; and

selected from laponite, silver-carrying zeolite, dibutylhydroxytoluene, caulis Sacchari sinensis extract, folium Eriobotryae extract, rhizoma Iridis Tectori extract, folium Perillae extract, and hydroxypropyl-β-at least one of group 3 of cyclodextrins, herbal extracts, green tea extracts, and combinations thereof,

The deodorant and the passivating agent according to the present disclosure are described in the above embodiments and examples, but are not limited to the above embodiments and examples, and various modifications, alterations, and improvements can be made to the disclosed elements (including the elements described in the claims, the description, and the drawings) within the scope of the present invention and according to the basic technical idea of the present invention. In addition, various combinations, substitutions, and selections of the disclosed elements may be made within the scope of the claims of the present invention.

Further objects, objects and aspects (including variations) of the present invention will become apparent from the entire disclosure of the invention including the claims.

In the present specification, the numerical ranges described herein are to be construed as the numerical values or ranges specifically described herein, even if not specifically stated otherwise.

Claims

1. An agent for combating stress odour, comprising at least one component selected from the group consisting of:<1>spearmint oil;<2>mixed lavender oil;<3>peppermint oil;<4>l-citronellal;<5>linalool;<6>dihydromyrcenol;<7>cis-3-hexenol;<8>ligustral;<9>benzyl acetate;<10>rosemary oil;<11>cis-3-hexenyl acetate;<12>lavender oil;<13>(R) -3, 7-dimethyl-6-octenenitrile;<14>(1R,6S) -2,2, 6-trimethyl-cyclohexanecarboxylic acid ethyl ester;<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol;<19>(-) -isopulegol;<20>2- (tert-butyl) cyclohexyl acetate;<21> β-damascone;<22>hexyl acetate;<23>l-cis-rose oxide;<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol;<26>cedar oil;<27>geranium oil;<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene;<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal;<33>2- (2-mercapto group)-propan-2-yl) -5-methylcyclohexanone;<34>terpineol; and combinations thereof.

2. The tension odor preventive agent according to claim 1, which comprises at least one of the above-mentioned components <1> to <34> and combinations thereof as a masking agent against tension odor.

3. The tension odor preventive agent according to claim 1, which comprises at least one of the above-mentioned components <1> to <22> and combinations thereof as a blending agent against tension odor.

4. The tension odor preventive agent according to any one of claims 1 to 3, which comprises at least one of the above-mentioned components <1> to <22> and combinations thereof as a masking agent and a blending agent for tension odor.

5. A tension odor preventive agent as claimed in any one of claims 1 to 4, wherein the tension odor is an odor emitted from the body due to tension and/or psychological stress.

6. The odor control agent according to any one of claims 1 to 5, wherein the substance causing the odor control agent comprises at least one of allyl mercaptan and dimethyl trisulfide.

7. A tension stink-proof agent as claimed in claim 6, wherein said causative substance further contains at least one of dimethyl disulfide and methyl propyl trisulfide.

8. A tension stink-proof agent as claimed in claim 6 or 7, wherein said causative substance further comprises 1-octen-3-one.

9. A passivating agent comprising at least one ingredient selected from the group consisting of:<1>spearmint oil;<2>mixed lavender oil;<3>peppermint oil;<4>l-citronellal;<5>linalool;<6>dihydromyrceneAn alcohol;<7>cis-3-hexenol;<8>ligustral;<9>benzyl acetate;<10>rosemary oil;<11>cis-3-hexenyl acetate;<12>lavender oil;<13>(R) -3, 7-dimethyl-6-octenenitrile;<14>(1R,6S) -2,2, 6-trimethyl-cyclohexanecarboxylic acid ethyl ester;<15>eucalyptus oil;<16> γ-undecalactones;<17>rose oil;<18>(R) -2-methyl-4- (2,2, 3-trimethyl-3-cyclopenten-1-yl) -2-buten-1-ol;<19>(-) -isopulegol;<20>2- (tert-butyl) cyclohexyl acetate;<21> β-damascone;<22>hexyl acetate;<23>l-cis-rose oxide;<24>2-phenyl ethanol;<25>3, 7-dimethyl-1-octanol;<26>cedar oil;<27>geranium oil;<28>2-acetyl-2, 3,8, 8-tetramethyl-1, 2,3,4,5,6,7, 8-octahydronaphthalene;<29>citronellyl l-acetate;<30>geraniol;<31>1-phenylethyl acetate;<32>(3S,6E) -3,7, 11-trimethyldodecane-6, 10-dienal;<33>2- (2-mercaptopropan-2-yl) -5-methylcyclohexanone;<34>terpineol; and a combination thereof,

the passivator passivates the psychogenic and/or psychogenic active effects of secretory components.

10. The deactivator according to claim 9, wherein the secretory component is a component which is self-secreted due to stress and/or mental stress.

11. The inactivation reagent according to claim 9 or 10, wherein the secretory component comprises at least one of allyl thiol and dimethyl trisulfide.

12. The tension odor control agent as set forth in claim 11, wherein said secretory component further comprises at least one of dimethyl disulfide and methyl propyl trisulfide.

13. A deactivant according to claim 11 or 12, wherein the secretory component further comprises 1-octen-3-one.